Jifei Wang

749 total citations
45 papers, 429 citations indexed

About

Jifei Wang is a scholar working on Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jifei Wang has authored 45 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jifei Wang's work include Cancer-related molecular mechanisms research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Acute Myocardial Infarction Research (6 papers). Jifei Wang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Acute Myocardial Infarction Research (6 papers). Jifei Wang collaborates with scholars based in China, Australia and Germany. Jifei Wang's co-authors include Zhenhua Gao, Honglun Wang, Yaodong Zhang, Shi‐Ting Feng, Yuming Wang, Changxian Li, Wangjie Jiang, Meng Quanfei, Yirui Wang and Meili Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Food Chemistry.

In The Last Decade

Jifei Wang

43 papers receiving 424 citations

Peers

Jifei Wang
Hyunji Kim South Korea
Zina Zhang United States
Long Bai China
Hyunji Kim South Korea
Jifei Wang
Citations per year, relative to Jifei Wang Jifei Wang (= 1×) peers Hyunji Kim

Countries citing papers authored by Jifei Wang

Since Specialization
Citations

This map shows the geographic impact of Jifei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifei Wang more than expected).

Fields of papers citing papers by Jifei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jifei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifei Wang. The network helps show where Jifei Wang may publish in the future.

Co-authorship network of co-authors of Jifei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jifei Wang. A scholar is included among the top collaborators of Jifei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jifei Wang. Jifei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jifei, Qinfeng Xu, Hongwei Wang, et al.. (2025). Aldose reductase -mediated HUR ubiquitination enhances exosome release and hepatic fibrosis via ROS/PI3K/AKT pathway. Free Radical Biology and Medicine. 236. 1–16.
2.
Zhou, Tao, Yaodong Zhang, Jiang Chang, et al.. (2025). NRXN3 regulates pyroptosis in intrahepatic cholangiocarcinoma via mediating the phospho-dependent ubiquitination and degradation of caspase-3. Journal of Advanced Research. 80. 655–669. 1 indexed citations
3.
Wang, Jifei, Zhaoying Li, Guang Yang, et al.. (2024). Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography. Clinica Chimica Acta. 554. 117745–117745. 1 indexed citations
4.
Xu, Xiao, Jifei Wang, Yuming Wang, et al.. (2024). USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma. International Journal of Biological Sciences. 20(4). 1492–1508. 15 indexed citations
5.
Qiao, Qian, Jifei Wang, Jiang Chang, et al.. (2024). USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma. Cellular Oncology. 47(6). 2217–2231. 3 indexed citations
6.
Wang, Yirui, Ming Ni, Ruixiang Chen, et al.. (2024). Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway. Free Radical Biology and Medicine. 220. 78–91. 2 indexed citations
7.
Wang, Yuming, Yiwei Liu, Hairong Chen, et al.. (2024). PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2. Cellular Oncology. 47(4). 1233–1252. 4 indexed citations
8.
Zhou, Xiaoqi, Chenyu Song, Zhi Dong, et al.. (2023). Preoperative assessment of peripheral vascular invasion of pancreatic ductal adenocarcinoma based on high-resolution MRI. BMC Cancer. 23(1). 1092–1092. 3 indexed citations
9.
Froelich, Matthias F., Hong Jiang, Yuanqi Wang, et al.. (2023). Computed tomography imaging phenotypes of hepatoblastoma identified from radiomics signatures are associated with the efficacy of neoadjuvant chemotherapy. Pediatric Radiology. 54(1). 58–67. 5 indexed citations
11.
Jiang, Wangjie, Tao Zhou, Yaodong Zhang, et al.. (2023). NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1. International Journal of Biological Sciences. 19(5). 1336–1351. 13 indexed citations
12.
Jiang, Wangjie, Xiao Yang, Yaodong Zhang, et al.. (2023). MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex. Oncogene. 42(45). 3344–3357. 10 indexed citations
13.
Wang, Yirui, Yaodong Zhang, Tao Zhou, et al.. (2023). Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. Journal of Experimental & Clinical Cancer Research. 42(1). 265–265. 26 indexed citations
14.
Zhou, Tao, Yaodong Zhang, Jifei Wang, et al.. (2022). ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal. Frontiers in Oncology. 12. 879963–879963. 2 indexed citations
15.
Yin, Yan-Wei, Chao Fang, Jifei Wang, et al.. (2022). Optical Coherence Tomographic Features of Pancoronary Plaques in Patients With Acute Myocardial Infarction Caused by Layered Plaque Rupture Versus Layered Plaque Erosion. The American Journal of Cardiology. 167. 35–42. 3 indexed citations
16.
Zhou, Xiaoqi, Jifei Wang, Mimi Tang, et al.. (2020). Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge. BMC Cancer. 20(1). 54–54. 14 indexed citations
17.
Fang, Chao, Jiannan Dai, Yidan Wang, et al.. (2019). Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study. Atherosclerosis. 289. 94–100. 27 indexed citations
18.
Wang, Jifei, Ling Xu, Ziping Li, et al.. (2019). Constructing an experiential education model in undergraduate radiology education by the utilization of the picture archiving and communication system (PACS). BMC Medical Education. 19(1). 383–383. 10 indexed citations
19.
Liu, Jianghui, et al.. (2019). <p>miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1</p>. Cancer Management and Research. Volume 11. 5573–5587. 21 indexed citations
20.
Shen, Dongdong, et al.. (2017). Genetic diversity of Haemonchus contortus isolated from sympatric wild blue sheep (Pseudois nayaur) and sheep in Helan Mountains, China. Parasites & Vectors. 10(1). 437–437. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026